Stockport, United Kingdom

Michael Lingard Swain


Average Co-Inventor Count = 2.8

ph-index = 5

Forward Citations = 83(Granted Patents)


Location History:

  • Macclesfield, Cheshire, SK10 4TG, GB (2002)
  • Stockport, GB (1995 - 2008)
  • Cheshire, GB (1997 - 2008)

Company Filing History:


Years Active: 1995-2008

Loading Chart...
10 patents (USPTO):Explore Patents

Title: Michael Lingard Swain: Innovator in Antibacterial Agents

Introduction

Michael Lingard Swain is a notable inventor based in Stockport, GB. He has made significant contributions to the field of pharmaceuticals, particularly in the development of antibacterial agents. With a total of 10 patents to his name, Swain's work has had a considerable impact on medical science.

Latest Patents

Swain's latest patents include innovative compounds such as oxazolidinone and isoxazoline, which are recognized for their antibacterial properties. These compounds are described by specific formulas, including pharmaceutically acceptable salts and in-vivo-hydrolysable esters. His research also encompasses antibiotic compounds related to carbapenems, showcasing his commitment to advancing medical treatments.

Career Highlights

Throughout his career, Swain has worked with prominent companies in the pharmaceutical industry, including Zeneca Limited and AstraZeneca UK Limited. His experience in these organizations has allowed him to develop and refine his inventions, contributing to the advancement of healthcare solutions.

Collaborations

Swain has collaborated with notable colleagues such as Michael John Betts and Gareth Morse Davies. These partnerships have facilitated the exchange of ideas and expertise, further enhancing the quality of his work.

Conclusion

Michael Lingard Swain's contributions to the field of antibacterial agents through his patents and collaborations highlight his role as an influential inventor. His work continues to pave the way for advancements in pharmaceutical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…